Corticosteroids

Asthma and COPD

Volumn , Issue , 2009, Pages 639-653

  Barnes, Peter J ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650342027     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374001-4.00051-1     Document Type: Chapter

References (132)

1. Barnes PJ How corticosteroids control inflammation. Br J Pharmacol 2006, 148:245-254.
2. Rhen T, Cidlowski JA Antiinflammatory action of glucocorticoids - New mechanisms for old drugs. N Engl J Med 2005, 353:1711-1723.
3. Gibson PG, Saltos N, Fakes K Acute anti-inflammatory effects of inhaled budesonide in asthma: A randomized controlled trial. Am J Respir Crit Care Med 2001, 163:32-36.
4. Ketchell RI, Jensen MW, Lumley P, Wright AM, Allenby MI, O'Connor BJ Rapid effect of inhaled fluticasone propionate on airway responsiveness to adenosine 5'-monophosphate in mild asthma. J Allergy Clin Immunol 2002, 110:603-606.
5. Juniper EF, Kline PA, Yan Zieleshem MA, Ramsdale EH, O'Byrne PM, Hargreave FE Long-term effects of budesonide on airway responsiveness and clinical asthma severity in inhaled steroid-dependent asthmatics. Eur Respir J 1990, 3:1122-1127.
6. Lewis-Tuffin LJ, Cidlowski JA The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Ann NY Acad Sci 2006, 1069:1-9.
7. Pujols L, Mullol J, Picado C Alpha and beta glucocorticoid receptors: Relevance in airway diseases. Curr Allergy Asthma Rep 2007, 7:93-99.
8. Barnes PJ Corticosteroid effects on cell signalling. Eur Respir J 2006, 27:413-426.
9. Clark AR MAP kinase phosphatase 1: A novel mediator of biological effects of glucocorticoids?. J Endocrinol 2003, 178:5-12.
10. Dostert A, Heinzel T Negative glucocorticoid receptor response elements and their role in glucocorticoid action. Curr Pharm Des 2004, 10:2807-2816.
11. Barnes PJ, Adcock IM How do corticosteroids work in asthma?. Ann Intern Med 2003, 139:359-370.
12. Barnes PJ, Adcock IM, Ito K Histone acetylation and deacetylation: Importance in inflammatory lung diseases. Eur Respir J 2005, 25:552-563.
13. Hart L, Lim S, Adcock I, Barnes PJ, Chung KF Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor-kB in asthma. Am J Respir Crit Care Med 2000, 161:224-231.
14. Ito K, Barnes PJ, Adcock IM Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits IL-1b-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol 2000, 20:6891-6903.
15. Bergmann MW, Staples KJ, Smith SJ, Barnes PJ, Newton R Glucocorticoid inhibition of GM-CSF from T cells is independent of control by NF-κB and CLE0. Am J Respir Cell Mol. Biol 2004, 30:555-563.
16. Brook M, Tchen CR, Santalucia T, McIlrath J, Arthur JS, Saklatvala J, et al. Posttranslational regulation of tristetraprolin subcellular localization and protein stability by p38 mitogen-activated protein kinase and extracellular signal-regulated kinase pathways. Mol Cell Biol 2006, 26:2408-2418.
17. Thomson NC, Spears M The influence of smoking on the treatment response in patients with asthma. Curr Opin Allergy Clin Immunol 2005, 5:57-63.
18. Adcock IM, Lane SJ Corticosteroid-insensitive asthma: Molecular mechanisms. J Endocrinol 2003, 178:347-355.
19. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 2005, 352:1967-1976.
20. Hew M, Bhavsar P, Torrego A, Meah S, Khorasani N, Barnes PJ, et al. Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am J Respir Crit Care Med 2006, 174:134-141.
21. Barnes PJ Reduced histone deacetylase in COPD: Clinical implications. Chest 2006, 129:151-155.
22. Irusen E, Matthews JG, Takahashi A, Barnes PJ, Chung KF, Adcock IM p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: Role in steroid-insensitive asthma. J Allergy Clin Immunol 2002, 109:649-657.
23. Matthews JG, Ito K, Barnes PJ, Adcock IM Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J Allergy Clin Immunol 2004, 113:1100-1108.
24. Barnes PJ Scientific rationale for combination inhalers with a long-acting β2-agonists and corticosteroids. Eur Respir J 2002, 19:182-191.
25. Mak JCW, Nishikawa M, Barnes PJ Glucocorticosteroids increase β 2-adrenergic receptor transcription in human lung. Am J Physiol 1995, 12:L41-L46.
26. Baraniuk JN, Ali M, Brody D, Maniscalco J, Gaumond E, Fitzgerald T, et al. Glucocorticoids induce β 2-adrenergic receptor function in human nasal mucosa. Am J Respir Crit Care Med 1997, 155:704-710.
27. Mak JCW, Nishikawa M, Shirasaki H, Miyayasu K, Barnes PJ Protective effects of a glucocorticoid on down-regulation of pulmonary β 2-adrenergic receptors in vivo. J Clin Invest 1995, 96:99-106.
28. Mak JC, Chuang TT, Harris CA, Barnes PJ Increased expression of G protein-coupled receptor kinases in cystic fibrosis lung. Eur J Pharmacol 2002, 436:165-172.
29. Roth M, Johnson PR, Rudiger JJ, King GG, Ge Q, Burgess JK, et al. Interaction between glucocorticoids and β2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Lancet 2002, 360:1293-1299.
30. Usmani OS, Ito K, Maneechotesuwan K, Ito M, Johnson M, Barnes PJ, et al. Glucocorticoid receptor nuclear translocation in airway cells following inhaled combination therapy. Am J Respir Crit Care Med 2005, 172:704-712.
31. Gambertoglio JG, Amend WJC, Benet LZ Pharmacokinetics and bioavailability of prednisone and prednisolone in healthy volunteers and patients: A review. J Pharmacokin Biopharm 1980, 8:1-52.
32. Barnes PJ, Pedersen S, Busse WW Efficacy and safety of inhaled corticosteroids: An update. Am J Respir Crit Care Med 1998, 157:S1-S53.
33. Lipworth BJ Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis [see comments]. Arch Intern Med 1999, 159:941-955.
34. Derendorf H, Hochhaus G, Meibohm B, Mollmann H, Barth J Pharmacokinetics and pharmacodynamics of inhaled corticosteroids. J Allergy Clin Immunol 1998, 101:S440-S446.
35. Brown PH, Greening AP, Crompton GK Large volume spacer devices and the influence of high dose beclomethasone diproprionate on hypothalamo-pituitary-adrenal axis function. Thorax 1993, 48:233-238.
36. Derendorf H Corticosteroid pharmacokinetic/pharmacodynamic parameters and their relationship to safety and efficacy. Allergy Asthma Proc 2005, 26:327-335.
37. Derendorf H Pharmacokinetic and pharmacodynamic properties of inhaled ciclesonide. J Clin Pharmacol 2007, 47:782-789.
38. Harrison BDN, Stokes TC, Hart GJ, Vaughan DA, Ali NJ, Robinson AA Need for intravenous hydrocortisone in addition to oral prednisolone in patients admitted to hospital with severe asthma without ventilatory failure. Lancet 1986, i:181-184.
39. Storr J, Barrell E, Barry W, Lenney W, Hatcher G Effect of a single oral dose of prednisolone in acute childhood asthma. Lancet 1987, 1:879-882.
40. Levy ML, Stevenson C, Maslen T Comparison of short courses of oral prednisolone and fluticasone propionate in the treatment of adults with acute exacerbations of asthma in primary care. Thorax 1996, 51:1087-1092.
41. Manjra AI, Price J, Lenney W, Hughes S, Barnacle H Efficacy of nebulized fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. Respir Med 2000, 94:1206-1214.
42. Harrison TW, Oborne J, Newton S, Tattersfield AE Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: Randomised controlled trial. Lancet 2004, 363:271-275.
43. FitzGerald JM, Becker A, Sears MR, Mink S, Chung K, Lee J Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax 2004, 59:550-556.
44. Foresi A, Morelli MC, Catena E Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. On behalf of the Italian Study Group. Chest 2000, 117:440-446.
45. Edmonds ML, Camargo CA, Pollack CV, Rowe BH Early use of inhaled corticosteroids in the emergency department treatment of acute asthma. Cochrane Database Syst Rev 2003, CD002308.
46. Global Initiative for Asthma. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report. www.ginasthma.com 2006. http://www.ginasthma.com.
47. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, et al. Comparison of a β2-agonist terbutaline with an inhaled steroid in newly detected asthma. N Engl J Med 1991, 325:388-392.
48. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990, 142:832-836.
49. Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, et al. Early intervention with budesonide in mild persistent asthma: A randomised, double-blind trial. Lancet 2003, 361:1071-1076.
50. Mash B, Bheekie A, Jones PW Inhaled vs oral steroids for adults with chronic asthma. Cochrane Database Syst Rev 2002, 2. CD002160:CD002160.
51. Vathenen AS, Knox AJ, Wisniewski A, Tattersfield AE Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis 1991, 143:1317-1321.
52. Jatakanon A, Lim S, Barnes PJ Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000, 161:64-672.
53. Leuppi JD, Salome CM, Jenkins CR, Anderson SD, Xuan W, Marks GB, et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med. 2001, 163:406-412.
54. van Essen-Zandvliet EE, Hughes MD, Waalkens HJ, Duiverman EJ, Pocock SJ, Kerrebijn KF Effects of 22 months of treatment with inhaled corticosteroids and/or β 2-agonists on lung function, airway responsiveness and symptoms in children with asthma. Am Rev Respir Dis 1992, 146:547-554.
55. Waalkens HJ, van Essen-Zandvliet EE, Hughes MD, Gerritsen J, Duiverman EJ, Knol K, et al. Cessation of long-term treatment with inhaled corticosteroids (budesonide) in children with asthma results in deterioration. Am Rev Respir Dis 1993, 148:1252-1257.
56. Berger WE Budesonide inhalation suspension for the treatment of asthma in infants and children. Drugs 1973, 65:1973-1989.
57. Busse WW, Chervinsky P, Condemi J, Lumry WR, Petty TL, Rennard S, et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. J Allergy Clin Immunol 1998, 101:457-463.
58. Adams NP, Jones PW The dose-response characteristics of inhaled corticosteroids when used to treat asthma: An overview of Cochrane systematic reviews. Respir Med 2006, 100:1297-1306.
59. Pauwels RA, Lofdahl C-G, Postma DS, Tattersfield AE, O'Byrne PM, Barnes PJ, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997, 337:1412-1418.
60. Lim S, Jatakanon A, John M, Gilbey T, O'Connor BJ, Chung KF, et al. Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma. Am J Respir Crit Care Med 1999, 159:22-30.
61. Jatakanon A, Lim S, Chung KF, Barnes PJ An inhaled steroid improves markers of inflammation in asymptomatic steroid-naive asthmatic patients. Eur Respir J 1998, 12:1084-1088.
62. Jatakanon A, Kharitonov S, Lim S, Barnes PJ Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma. Thorax 1999, 54:108-114.
63. Kharitonov SA, Donnelly LE, Montuschi P, Corradi M, Collins JV, Barnes PJ Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma. Thorax 2002, 57:889-896.
64. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long- term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999, 159:1043-1051.
65. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: A randomised controlled trial. Lancet 2002, 360:1715-1721.
66. Jayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemiere C, Pizzichini E, et al. Determining asthma treatment by monitoring sputum cell counts: Effect on exacerbations. Eur Respir J 2006, 27:483-494.
67. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005, 352:2163-2173.
68. Dompeling E, Van Schayck CP, Molema J, Folgering H, van Grusven PM, van Weel C Inhaled beclomethasone improves the course of asthma and COPD. Eur Resp J 1992, 5:945-952.
69. O'Byrne PM, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, et al. Effects of early intervention with inhaled budesonide on lung function in newly diagnosed asthma. Chest 2006, 129:1478-1485.
70. Lange P, Scharling H, Ulrik CS, Vestbo J Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax 2006, 61:100-104.
71. Haahtela T, Järvinsen M, Kava T, Kiviranta K, Koskinen S, Lemtonen K, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994, 331:700-705.
72. Agertoft L, Pedersen S Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Resp Med 1994, 5:369-372.
73. Selroos O, Pietinalcho A, Lofroos A-B, Riska A Effect of early and late intervention with inhaled corticosteroids in asthma. Chest 1995, 108:1228-1234.
74. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 2000, 343:332-336.
75. Ernst P, Habbick B, Suissa S, Hemmelgarn B, Cockcroft D, Buist AS, et al. Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity?. Am Rev Respir Dis 1993, 148:75-79.
76. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM The Salmeterol Multicenter Asthma Research Trial: A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006, 129:15-26.
77. Nathan RA, Nayak AS, Graft DF, Lawrence M, Picone FJ, Ahmed T, et al. Mometasone furoate: Efficacy and safety in moderate asthma compared with beclomethasone dipropionate. Ann Allergy Asthma Immunol 2001, 86:203-210.
78. Reynolds NA, Scott LJ Ciclesonide. Drugs 2004, 64:511-519.
79. Malo J-L, Cartier A, Merland N, Ghezzo H, Burke A, Morris J, et al. Four-times-a-day dosing frequency is better than twice-a-day regimen in subjects requiring a high-dose inhaled steroid, budesonide, to control moderate to severe asthma. Am Rev Respir Dis 1989, 140:624-628.
80. Otulana BA, Varma N, Bullock A, Higenbottam T High dose nebulized steroid in the treatment of chronic steroid-dependent asthma. Resp Med 1992, 86:105-108.
81. Hawkins G, McMahon AD, Twaddle S, Wood SF, Ford I, Thomson NC Stepping down inhaled corticosteroids in asthma: Randomised controlled trial. BMJ 2003, 326:1115.
82. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of COPD-2006 Update. Am J Respir Crit Care Med 2007, 176:532-555.
83. Yang IA, Fong KM, Sim EH, Black PN, Lasserson TJ Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database. Syst Rev 2007, CD002991.
84. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007, 356:775-789.
85. Kankaanranta H, Lahdensuo A, Moilanen E, Barnes PJ Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: A comprehensive review. Respir Res 2004, 5:17.
86. Greening AP, Ind PW, Northfield M, Shaw G Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994, 344:219-224.
87. Shrewsbury S, Pyke S, Britton M Meta-analysis of increased dose of inhaled steroid or addition of salmeterol in symptomatic asthma (MIASMA). BMJ 2000, 320:1368-1373.
88. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, et al. Low dose inhaled budesonide and formoterol in mild persistent asthma: The OPTIMA randomized trial. Am J Respir Crit Care Med 2001, 164:1392-1397.
89. Gibson PG, Powell H, Ducharme FM Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations. J Allergy Clin Immunol 2007, 119:344-350.
90. Ni CM, Greenstone IR, Ducharme FM Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults. Cochrane Database Syst. Rev 2005, CD005307.
91. O'Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Resp Crit Care Med 2005, 171:129-136.
92. Rabe KF, Pizzichini E, Stallberg B, Romero S, Balanzat AM, Atienza T, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: A randomized, double-blind trial. Chest 2006, 129:246-256.
93. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: A randomised controlled, double-blind study. Lancet 2006, 368:744-753.
94. Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer CA, O'Byrne PM, et al. Exacerbations of asthma. A descriptive study of 425 severe exacerbations. Am J Respir Crit Care Med 1999, 160:594-599.
95. Barnes PJ New therapies for asthma. Trends Mol Med 2006, 12:515-520.
96. Calverley P, Pauwels R, Vestbo J, Jones P, Pride N, Gulsvik A, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: A randomoised controlled trial. Lancet 2003, 361:449-456.
97. Szafranski W, Cukier A, Ramirez A, Menga G, Sansores R, Nahabedian S, et al. Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease. Eur Respir J 2003, 21:74-81.
98. Nannini L, Cates C, Lasserson T, Poole P Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007, CD006829.
99. Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008, 177:19-26.
100. Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997, 337:1412-1418.
101. Ukena D, Harnest U, Sakalauskas R, Magyar P, Vetter N, Steffen H, et al. Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma. Eur Respir J 1997, 10:2754-2760.
102. Lim S, Jatakanon A, Gordon D, Macdonald C, Chung KF, Barnes PJ Comparison of high dose inhaled steroids, low dose inhaled steroids plus low dose theophylline, and low dose inhaled steroids alone in chronic asthma in general practice. Thorax 2000, 55:837-841.
103. Wilson AJ, Gibson PG, Coughlan J Long acting beta-agonists versus theophylline for maintenance treatment of asthma. Cochrane Database Syst Rev 2000, CD001281.
104. Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I, et al. Montelukast added to inhaled beclomethasone in treatment of asthma. Am J Respir Crit Care Med 1999, 160:1862-1868.
105. Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG, et al. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 2003, 58:211-216.
106. Nelson HS, Busse WW, Kerwin E, Church N, Emmett A, Rickard K, et al. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol 2000, 106:1088-1095.
107. Ducharme F, Schwartz Z, Hicks G, Kakuma R Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev 2004, CD003133.
108. Ducharme FM, Lasserson TJ, Cates CJ Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Cochrane Database Syst Rev 2006, CD003137.
109. Williamson IJ, Matusiewicz SP, Brown PH, Greening AP, Crompton GK Frequency of voice problems and cough in patients using pressurised aersosol inhaled steroid preparations. Eur Resp J 1995, 8:590-592.
110. Toogood JA, Jennings B, Greenway RW, Chung L Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol 1980, 65:145-153.
111. Ernst P, Gonzalez AV, Brassard P, Suissa S Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 2007, 176:162-166.
112. Kamada AK, Szefler SJ, Martin RJ, Boushey HA, Chinchilli VM, Drazen JM, et al. Issues in the use of inhaled steroids. Am J Respir Crit Care Med 1996, 153:1739-1748.
113. Brutsche MH, Brutsche IC, Munawar M, Langley SJ, Masterson CM, Daley-Yates PT, et al. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: A randomised crossover study. Lancet 2000, 356:556-561.
114. Harrison TW, Wisniewski A, Honour J, Tattersfield AE Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Thorax 2001, 56:186-191.
115. Efthimou J, Barnes PJ Effect of inhaled corticosteroids on bone and growth. Eur Respir J 1998, 11:1167-1177.
116. Roy A, Leblanc C, Paquette L, Ghezzo H, Cote J, Cartier A, et al. Skin bruising in asthmatic subjects treated with high does of inhaled steroids: Frequency and association with adrenal function. Eur Respir J 1996, 9:226-231.
117. Simons FER, Persaud MP, Gillespie CA, Cheang M, Shuckett EP Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids. Lancet 1993, 342:736-738.
118. Garbe E, LeLorier J, Boivin J-F, Suissa S Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA 1997, 227:722-727.
119. Pedersen S Do inhaled corticosteroids inhibit growth in children?. Am J Respir Crit Care Med 2001, 164:521-535.
120. Allen DB, Mullen M, Mullen B A meta-analysis of the effects of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol 1994, 93:967-976.
121. Silverstein MD, Yunginger JW, Reed CE, Petterson T, Zimmerman D, Li JT, et al. Attained adult height after childhood asthma: Effect of glucocorticoid therapy. J Allergy Clin Immunol 1997, 99:466-474.
122. Agertoft L, Pedersen S Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000, 343:1064-1069.
123. Schatz M Asthma and pregnancy. Lancet 1999, 353:1202-1204.
124. Ernst P, Baltzan M, Deschenes J, Suissa S Low-dose inhaled and nasal corticosteroid use and the risk of cataracts. Eur Respir J 2006, 27:1168-1174.
125. Beam WR, Ballard RD, Martin RJ Spectrum of corticosteroid sensitivity in nocturnal asthma. Am Rev Respir Dis 1992, 145:1082-1086.
126. McLeod DT, Capewell SJ, Law J, MacLaren W, Seaton A Intramuscular triamcinolone acetamide in chronic severe asthma. Thorax 1985, 40:840-845.
127. Ogirala RG, Aldrich TK, Prezant DJ, Sinnett MJ, Enden JB, Williams MH High dose intramuscular triamcinolone in severe life-threatening asthma. N Engl J Med 1991, 329:585-589.
128. Engel T, Heinig JH Glucocorticoid therapy in acute severe asthma-a critical review. Eur Respir J 1991, 4:881-889.
129. Decramer M, Lacquet LM, Fagard R, Rogiers P Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med 1995, 150:11-16.
130. Bowler SD, Mitchell CA, Armstrong JG Corticosteroids in acute severe asthma: Effectiveness of low doses. Thorax 1992, 47:584-587.
131. Morell F, Orkiols R, de Gracia J, Curul V, Pujol A Controlled trial of intravenous corticosteroids in severe acute asthma. Thorax 1992, 47:588-591.
132. Devidayal, Singhi S, Kumar L, Jayshree M Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma. Acta Paediatr 1999, 88:835-840.